🇺🇸 FDA
Patent

US 6878550

13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

expired A61KA61K51/1206

Quick answer

US patent 6878550 (13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control) held by Isotechnika, Inc. expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Isotechnika, Inc.
Grant date
Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K51/1206